Volume 15, Issue 12 (12-2017)                   IJRM 2017, 15(12): 779-786 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zare Z, Abouhamzeh B, Masteri Farahani R, Salehi M, Mohammadi M. Supplementation of L-carnitine during in vitro maturation of mouse oocytes affects expression of genes involved in oocyte and embryo competence: An experimental study. IJRM. 2017; 15 (12) :779-786
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-928-en.html
1- Department of Anatomical Sciences, School of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran
2- Department of Anatomical Sciences, School of Medicine, AJA University of Medical Sciences, Tehran, Iran
3- Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
5- Department of Physiology and Pharmacology, Molecular and Cell Biology Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran , mohammadimo@yahoo.com
Full-Text [PDF 256 kb]   (212 Downloads)     |   Abstract (HTML)  (1016 Views)
Full-Text:   (60 Views)
Introduction
 
In vitro maturation (IVM) of oocytes has been proposed as an option for infertility treatment (1). Despite the increasing application of IVM in recent years, reduced meiotic maturation and low embryos production can lead to developmental inadequacy of oocytes when compared with in vivo-matured oocytes (2).
Selection of the best quality oocytes is a determining factor in successful IVM and subsequent IVF program (3). A reliable test for selecting fully grown oocytes is brilliant cresyl blue (BCB) staining. BCB, a vital dye, determines the intracellular activity of glucose-6-phosphate dehydrogenase. During the oocytes growth phase, this enzyme is synthesized and then in fully grown oocytes, its activity is declined (4, 5).
Glucose-6-phosphate dehydrogenase converts BCB from blue to a colorless state, making the cytoplasm of fully grown oocytes into blue color (BCB+) (6). In this regard, previous studies have shown that BCB staining can help selecting competent oocytes, in terms of nuclear maturation and development, in some species, such as pig, sheep, and bovine (7-9).
Oxidative stress may have detrimental effects on oocyte, fertilization process, and subsequent embryo development (10, 11). L-carnitine (LC) is an endogenous substance which promotes transportation of fatty acids from the cytosol into the mitochondria for beta-oxidation and finally ATP production required for embryo development (12). Besides its significant role in the lipid metabolism, LC has protective effects on the cell through its antioxidant (free radical scavenger), anti-cytokine, and anti-apoptotic actions (13-15). It has been demonstrated that LC supplementation in either maturation or culture media can enhance maturation and developmental potential of camel oocytes (16). LC presumably has beneficial effects in improving yield of assisted reproductive technologies (17, 18).
The oocyte is very sensitive to changes in its micro-environment (19). Expression of many transcripts in oocytes may be up- or down-regulated with changes in culture media and conditions that affect maturation, fertilization, and embryo viability (20). Establishment of an in vitro maturation system and selection of good quality oocytes can have important implications for improving IVF and related techniques.
Therefore, the aim of this research was to evaluate the effect of LC supplementation during IVM of mouse immature oocytes, selected with BCB staining, on fertilization rate, preimplantation development, and the expression of genes involved in cell cycle regulation in mature oocytes (Ccnb1 and Mos), the maternal-effect genes in two-cell stage embryos (Ces5 and Dppa2), and the anti- and pro-apoptotic genes in blastocysts derived from BCB+ oocytes (Bcl-xL and Bax, respectively).
 
Materials and methods
 
Chemicals
All reagents used in this study were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA), unless specified.
 
Animals
In this experimental study, 80 NMRI mice (female, 6-8 wk and male, 8-12 wk) were obtained from Pasteur Institute, Tehran, Iran). Animals were housed in a temperature- controlled room with a 12 hr light/dark cycle and free access to food and water.

Collection of oocytes and BCB staining
Forty eight hr after superovulation with an intraperitoneal injection of 10 IU pregnant mareʼs serum gonadotropin, mice were sacrificed by cervical dislocation. Cumulus-oocyte complexes (COCs) were mechanically isolated from ovaries by puncturing antral follicles with 26-gauge needles. Almost 25-30 COCs were obtained from the ovaries of each mouse (at least 240 COCs/group). COCs were incubated in potassium simplex optimized medium (KSOM) supplemented with 0.04 mg/ml bovine serum albumin (BSA) containing 26 μM BCB for 90 min at 37oC in the presence of 6% CO2 under maximum humidity (4). BCB+ oocytes, colored cytoplasm, were selected.
 
In vitro oocyte maturation and embryo production
Procedure for IVM of BCB+ oocytes was that described previously, with some modifications (21). Briefly, oocytes were cultured in IVM medium (TCM 199, with Earle’s salt and L- glutamine, Gibco, Life Tech. Co., UK. enriched with, 24.2 mg/l sodium pyruvate, 1 µg/ml 17-β estradiol, 10 µg/ml LH, 10% FBS, and 10 µg/ml FSH) supplemented with 0.3 or 0.6 mg/ml LC, dissolved in TCM- 199.  In control group, oocytes were not treated with LC. The concentrations of LC were selected based on a previous research (22).
Oocytes were cultured for 24 hr at 37oC in the presence of 6% CO2 under maximum humidity. Thereafter, the nuclear maturation of oocytes was assessed using 10 μg/ml Hoechst 33342 under an inverted fluorescent microscope (Olympus, Tokyo, Japan). Percentage of metaphase I (MI, containing a metaphase plate, but without a polar body) and metaphase II (MII, containing a metaphasic plate and polar body) oocytes were measured. For sperm preparation, cauda epididymis of male mice was placed in 1 ml Ham's F10 medium supplemented with 5% BSA for 45 min. After maturation, MII oocytes (n=10) along with 25 µl of sperm suspension were added to the 100 µl droplet of fertilization medium (KSOM 15 mg/ml with BSA) and co-incubated for 6 hr at 37oC in a humidified atmosphere of 5% CO2. In each fertilization droplet, the final concentration of spermatozoa was about 3×106 sperm/ml (23). Fertilization rate was recorded as the percentage of 2-pronucleus embryos from the inseminated oocytes. The zygotes were cultured in 5% CO2 incubator at 37oC for 5 days. After this time, blastocyst development rate (BDR) was recorded.
 
Evaluation of blastocyst quality by differential staining
On the 5th day of embryo culture, differential staining method was used to count of trophectoderm (TE) and inner cell mass (ICM) cells (24). After washing of blastocysts and hatching blastocysts in flushing holding medium (FHM), zona pellucida was removed via incubation for 45 sec in Tyrode’s solution. The embryos exposed for 30 min to a 1:4 dilution of rabbit anti-mouse serum in FHM. Thereafter, they were incubated in 30% guinea pig complement in FHM supplemented with 10 μg/ml propidium iodide (PI) and 10μg/ml Hoechst 33342 for 30 min. Labeling of propidium iodide and Hoechst nuclei was observed using an epifluorescence microscope with an ultraviolet filter at ×400 magnification. Each embryo was assayed for the number of TE cells (pink or red nuclei) and the number of ICM (blue nuclei).
 
Total RNA extraction, cDNA synthesis, and quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
Reverse transcription of total RNA was performed using the cDNA synthesis kit (Thermo Fisher Scientific) primed with random hexamer primer according to the manufacturer’s protocol. Three pools of biological replicates (each replicate containing ten denuded mature oocytes, 5 two-cell stage embryos, or 2 blastocysts) were used. PCR was performed in triplicate for each sample. Primer sequences are listed in table I. Amplification of cDNA was carried out in a final volume of 13 µl of PCR mixture, consisted of 1 µl of the cDNA, 1 µl of forward and reverse primers, 6.5 μl of DNA Master SYBR Green I (Roche Applied Sciences), and 4.5 μl H2O using a Rotor Gene Q instrument (QIAGEN). The program was initial denaturation at 94oC (3 min), 40 cycles of 94oC (30 sec), 60oC (45 sec), and 72oC (45 sec). Hypoxanthine-guanine phospho-ribosyl-transferase (Hprt) was used as an internal reference gene (25). Results were then normalized with Hprt, calculated using 2-ΔΔCt, and expressed as relative fold change compared with controls (26).
 
Ethical consideration
All procedures were carried out in accordance with standards for care and use of laboratory animals approved by Ethical Committee of the Shahid Beheshti University of Medical Sciences, Tehran, Iran (SBMU.REC.1392.341).
 
Statistical analysis
Data were analyzed using the SPSS software (Statistical Package for the Social Sciences, version 19.0, SPSS Inc, Chicago, Illinois, USA). Results were presented as mean±SEM. The relative expression of genes, number of ICM and TE were analyzed using one-way analysis of variance (ANOVA), followed by Tukey’s post-hoc test for multiple comparisons. Comparison of maturation rate, fertilization rate, and BDR between groups was performed by Chi-square test. p<0.05 was considered to indicate statistical significance.

Table I. Primers used for qRT-PCR experiments


Results
 
Effect of LC on oocyte maturation
To determine if LC treatment alters the maturation rate of BCB+ oocytes, COCs were matured in vitro for 24 hr with/out 0.3 or 0.6 mg/ml LC, as described previously. As shown in table II, LC caused an increase (p<0.01) in maturation rate (75.8%±2 and 76.8%±2 in 0.3 and 0.6 mg/ml LC groups, respectively) as compared with untreated group (56.8%±2.8).
 
Effect of LC on embryo development potential
The effect of LC supplementation during IVM of BCB+ oocytes on fertilization rate and BDR are presented in table III. Adding 0.3 mg/ml of LC to IVM medium did not significantly affect the fertilization rate. The fertilization rate was significantly higher (p<0.01) in 0.6 mg/ml LC group compared with control group. Supplementation of IVM medium with 0.3 and 0.6 mg/ml LC significantly increased (p<0.01) the BDR. There was no significant effect of LC supplementation to IVM medium on the number of ICM and TE in blastocysts.
 
Effect of LC on the expression of maturation-related genes in oocytes
The results of qRT-PCR showed that in mature oocytes, the expression of Mos in both LC treated groups were higher than untreated group, although the differences were not statistically significant (Figure 1). However, treatment with both LC concentrations enhanced the expression of Ccnb1 compared with untreated group (p<0.01).
 
Effect of LC on the expression of maternal-effect genes in embryos
Maternal gene expression of Dppa2 and Ces5 in two-cell stage embryos was determined using qRT-PCR (Figure 1). Adding 0.3 mg/ml LC in IVM medium showed no significant effect on the expression of Dppa2. However, 0.6 mg/ml LC enhanced the mRNA expression of Dppa2 in two-cell stage embryos compared with untreated group (p<0.01). Adding 0.3 or 0.6 mg/ml LC to IVM medium had no effect on the mRNA expression of Ces5 in two-cell stage embryos.
 
Effect of LC on the expression of apoptosis-related genes in embryos
The expression of Bcl-xL and Bax were assessed in blastocysts. The results showed that LC treatment (0.3 and 0.6 mg/ml) during IVM of oocytes did not affect the mRNA level of Bax when compared with untreated group. Also, treatment of oocytes with LC (0.6 mg/ml) during IVM increased (p<0.01) the expression of Bcl-xL within blastocysts (Figure 1).


Table II. Effect of LC treatment during IVM on nuclear maturation of BCB+ oocytes


Table III. Effect of LC treatment during IVM of BCB+ oocytes on embryonic development after IVF




Figure 1. Effect of L-carnitine treatment during IVM on mRNA expression of Mos and Ccnb1 in MII oocytes; Dppa2 and Ces5 in two-cell stage embryos; and Bax and Bcl-xL in blastocysts. Different superscript letters for the same gene demonstrate a significant difference (p<0.01). Values represent mean±SEM of four experiments run in triplicate


Discussion
 
In the present study, we examined the effects of LC supplementation in the IVM medium of mouse BCB+ oocytes on preimplantation embryonic development. We have shown that LC effectively increased maturation rate of oocytes, fertilization rate, and BDR. In addition, LC improved expression levels of Ccnb1, Dppa2, and Bcl-xL mRNA in MII oocytes, two-cell stage embryos, and blastocysts, respectively.
Oocyte quality is an important factor in success of the assisted reproductive techniques. Moreover, it has been shown that existence of non-competent oocytes during IVM could negatively affect on developmental competence of oocytes and embryos (27). Among the vital analytic methods used for selecting competent oocytes, BCB staining is a useful technique and shows consistent results (28). It has been demonstrated that selection of competent immature oocytes with BCB test before IVM is efficient method, thus yielding higher in vitro blastocyst development (29).
On the other hand, the culture conditions of oocytes during IVM are critical factors for the successful development of in vitro-produced embryos (30). Also, development of a culture system that meets the requirements of the oocyte during IVM is crucial in order to produce a sufficient number of oocytes to be used clinically. LC is an antioxidant and has an important role in the transportation of long-chain fatty acids into the mitochondria for beta-oxidation and ATP production. ATP levels of oocytes may be responsible for oocyte maturation and developmental capacity of embryos after IVF (31). It was reported that LC has beneficial effects on embryonic development in the mouse, bovine, and porcine (30, 32, 33). We found that compared to control conditions, supplementation of IVM medium with LC significantly increased nuclear maturation rate.
Numerous factors are involved in cell cycle regulation. During oocyte maturation, accumulation of the proto-oncogene protein, Mos, activates mitogen-activated protein kinase (MAPK). During oocyte maturation, MAPK and maturation promoting factor (MPF) have critical functions in the adjustment of maternal gene expression. MPF is a complex protein, composed of two subunits: cyclin B or Ccnb1, and cdc2 (34). It has been shown that BCB+ oocytes possess the highest phosphorylation rate of MAPKs in MII stage, which may have positive effects on their developmental competence (6). Also, BCB+ oocytes showed a higher number of active mitochondria and MPF activity (8). We previously observed an increase in maturation rate, intracellular level of GSH, and mRNA expression of MAPK1 and CDK1 in mouse BCB+ oocytes after treatment with LC during IVM (23). The results of the present study demonstrated that adding of LC in the IVM medium of mouse BCB+ oocytes increased the Ccnb1 mRNA levels. It could be possible that the higher level of Ccnb1 mRNA may be due to improved oocyte maturation in these oocytes.
Oocyte competence, fertilization, and embryo quality are associated with the meiotic, cytoplasmic, and molecular maturation processes of the oocyte (35). Based on our results, supplementation of BCB+ oocytes with LC during IVM improved fertilization rate and BDR, but it had no significant effect on the number of ICM and TE in the blastocyst. Consistent with our findings, treatment of bovine oocytes with LC (0.6 mg/ml) during IVM improved developmental potential of oocytes and embryos; however, the number and ratio of inner cell mass and trophectoderm cells in blastocysts were unaltered when compared to the control (36). In contrast, treatment of bovine oocytes with different antioxidants such as the vitamin C, resveratrol, or carnitine during IVM induced an increase in total cell number in blastocysts (37). Supplementation of IVM medium with antioxidant reduces oxidative stress-induced embryotoxicity and alters the level of antioxidant enzymes (24).
Zygote gene activation depends on maternal transcripts and proteins that stored in oocyte during oogenesis and encoded by maternal-effect genes. These maternal products may activate the embryonic genomes and play fundamental roles at the maternal-zygotic stage transition in early embryonic development (38). In the present work, we measured the expression of the two maternal-effect genes (Ces5 and Dppa2) in two-cell stage embryos. Dppa2 (an Oct-4 related gene) is important for embryonic development (39). Our results showed that exposure of BCB+ oocytes during oocyte maturation to LC (0.6 mg/ml) significantly enhanced the expression of Dppa2 in these embryos. Although it is not clear how LC supplementation during IVM of immature oocytes can increase Dppa2 mRNA level, it can be concluded that improved maturation rate of oocytes and increased expression of Dppa2 may have a positive effect on developmental competence of these embryos.
Due to susceptibility of the embryos to oxidative stress after zygote gene activation, increased oxidative stress leads to apoptosis of embryos (40). LC acts as an antioxidant and could protect cells and embryos from damage caused by oxidative stress, mitochondria dysfunction, and ultimately inhibition of apoptosis (41, 42). Apoptotic index was lower while the expression of the Bcl-xL was higher in blastocysts derived from BCB+ oocytes than those from BCB- ones (28).
Thus, we assayed the expression of the Bcl-xL (an anti-apoptotic) and Bax (a pro-apoptotic) genes in blastocysts to determine whether apoptosis would be altered after treatment of BCB+ oocytes with LC. Our results showed that LC (0.3 or 0.6 mg/ml) added to IVM medium did not affect the level of Bax mRNA level in blastocysts. However, an increased expression of Bcl-xL was observed in blastocysts after treatment of oocytes with 0.6 mg/ml LC. It appears that there is a positive relationship between gene expression of Bcl-xL and the developmental competence in the embryos derived from oocytes treated with 0.6 mg/ml LC. The present findings are consistent with a previous report that supplementation of in vitro culture medium with LC (0.5 mg/ml) decreased the number of apoptotic cells in porcine activated blastocysts (41). It has been demonstrated that treatment of pig oocytes with LC (10 mM) increased the expression of both Bax and p-Bcl-xL mRNA in somatic cell nuclear transfer blastocysts. However, the cause of improved embryonic development despite increased expression of Bax mRNA after LC treatment was not clarified (30). Further investigations could elucidate the precise molecular mechanisms underlying LC function on developmental competence of oocytes and embryos.
Our study has some limitations that should be considered in the interpretation of the results. First, due to budget limitation, we did not measure genes expression at protein levels. Although alterations in mRNA levels do not necessarily reflect protein alterations, gene expression at mRNA level is still informative (43, 44). Second, in this study, we evaluated two apoptosis-related genes (i.e. Bax and Bcl-xL). Evaluation of other apoptosis-related genes, such as caspase-3, may increase the validity of our results. Studying the expression of other apoptosis-related genes should also be considered in our further study.
 
Conclusion
 
Our results showed that treatment of BCB+ oocytes with LC during IVM ameliorates the reproductive success by regulating expression of genes involved in normal embryonic development. Because of the similarity of human preimplantation development with that in mouse, our data may illustrate a possible role for the LC in culture media of human BCB+ oocytes which needs to be further examined in future studies.
 
Acknowledgments
 
This study was funded by Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences.
 
Conflict of interest
 
There is no conflict of interest in this study.


 
Type of Study: Original Article |

References
1. El Hachem H, Poulain M, Finet A, Fanchin R, Frydman N, Grynberg MH. Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro. Gynecol Endocrinol 2014; 30: 415-418. [DOI:10.3109/09513590.2014.893573]
2. Sonigo C, Grynberg M. In vitro oocyte maturation for female fertility preservation. Gynecol Obstet Fertil 2014; 42: 657-660. [DOI:10.1016/j.gyobfe.2014.07.009]
3. Nagai T. The improvement of in vitro maturation systems for bovine and porcine oocytes. Theriogenology 2001; 55: 1291-1301. [DOI:10.1016/S0093-691X(01)00483-6]
4. Bhojwani S, Alm H, Torner H, Kanitz W, Poehland R. Selection of developmentally competent oocytes through brilliant cresyl blue stain enhances blastocyst development rate after bovine nuclear transfer. Theriogenology 2007; 67: 341-345. [DOI:10.1016/j.theriogenology.2006.08.006]
5. Paramio MT, Izquierdo D. Recent advances in in vitro embryo production in small ruminants. Theriogenology 2016; 86: 152-159. [DOI:10.1016/j.theriogenology.2016.04.027]
6. Torner H, Ghanem N, Ambros C, Holker M, Tomek W, Phatsara C, et al. Molecular and subcellular characterisation of oocytes screened for their developmental competence based on glucose-6-phosphate dehydrogenase activity. Reproduction 2008; 135: 197-212. [DOI:10.1530/REP-07-0348]
7. Alm H, Torner H, Lohrke B, Viergutz T, Ghoneim IM, Kanitz W. Bovine blastocyst development rate in vitro is influenced by selection of oocytes by brillant cresyl blue staining before IVM as indicator for glucose-6-phosphate dehydrogenase activity. Theriogenology 2005; 63: 2194-2205. [DOI:10.1016/j.theriogenology.2004.09.050]
8. Catala MG, Izquierdo D, Uzbekova S, Morato R, Roura M, Romaguera R, et al. Brilliant Cresyl Blue stain selects largest oocytes with highest mitochondrial activity, maturation-promoting factor activity and embryo developmental competence in prepubertal sheep. Reprod 2011; 142: 517-527. [DOI:10.1530/REP-10-0528]
9. Fu B, Ren L, Liu D, Ma JZ, An TZ, Yang XQ, et al. Subcellular Characterization of Porcine Oocytes with Different Glucose-6-phosphate Dehydrogenase Activities. Asian-Australas J Anim Sci 2015; 28: 1703-1712. [DOI:10.5713/ajas.15.0051]
10. Baran V, Fabian D, Rehak P, Koppel J. Nucleolus in apoptosis-induced mouse preimplantation embryos. Zygote 2003; 11: 271-283. [DOI:10.1017/S0967199403002326]
11. Elamaran G, Singh KP, Singh MK, Singla SK, Chauhan MS, Manik RS, et al. Oxygen concentration and cysteamine supplementation during in vitro production of buffalo (Bubalus bubalis) embryos affect mRNA expression of BCL-2, BCL-XL, MCL-1, BAX and BID. Reprod Domest Anim 2012; 47: 1027-1036. [DOI:10.1111/j.1439-0531.2012.02009.x]
12. Vanella A, Russo A, Acquaviva R, Campisi A, Di Giacomo C, Sorrenti V, et al. L-propionyl-carnitine as superoxide scavenger, antioxidant, and DNA cleavage protector. Cell Biol Toxicol 2000; 16: 99-104. [DOI:10.1023/A:1007638025856]
13. Gulcin I. Antioxidant and antiradical activities of L-carnitine. Life Sci 2006; 78: 803-811. [DOI:10.1016/j.lfs.2005.05.103]
14. Qi SN, Zhang ZF, Wang ZY, Yoshida A, Ueda T. L-carnitine inhibits apoptotic DNA fragmentation induced by a new spin-labeled derivative of podophyllotoxin via caspase-3 in Raji cells. Oncol Rep 2006; 15: 119-122. [DOI:10.3892/or.15.1.119]
15. Winter BK, Fiskum G, Gallo LL. Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995; 72: 1173-1179. [DOI:10.1038/bjc.1995.482]
16. Fathi M, El-Shahat KH. L-carnitine enhances oocyte maturation and improves in vitro development of embryos in dromedary camels (Camelus dromedaries). Theriogenology 2017; 104: 18-22. [DOI:10.1016/j.theriogenology.2017.08.006]
17. Giorgi VS, Da Broi MG, Paz CC, Ferriani RA, Navarro PA. N-Acetyl-Cysteine and l-Carnitine Prevent Meiotic Oocyte Damage Induced by Follicular Fluid From Infertile Women With Mild Endometriosis. Reprod Sci 2016; 23: 342-351. [DOI:10.1177/1933719115602772]
18. Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2016; 84: 851-857. [DOI:10.1111/cen.13003]
19. Valckx SD, De Pauw I, De Neubourg D, Inion I, Berth M, Fransen E, et al. BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality. Hum Reprod 2012; 27: 3531-3539. [DOI:10.1093/humrep/des350]
20. Wrenzycki C, Herrmann D, Niemann H. Messenger RNA in oocytes and embryos in relation to embryo viability. Theriogenology 2007; 68 (Suppl.): S77-83. [DOI:10.1016/j.theriogenology.2007.04.028]
21. Wu YG, Liu Y, Zhou P, Lan GC, Han D, Miao DQ, et al. Selection of oocytes for in vitro maturation by brilliant cresyl blue staining: a study using the mouse model. Cell Res 2007; 17: 722-731. [DOI:10.1038/cr.2007.66]
22. Abdelrazik H, Sharma R, Mahfouz R, Agarwal A. L-carnitine decreases DNA damage and improves the in vitro blastocyst development rate in mouse embryos. Fertil Steril 2009; 91: 589-596. [DOI:10.1016/j.fertnstert.2007.11.067]
23. Zare Z, Masteri Farahani R, Salehi M, Piryaei A, Ghaffari Novin M, Fadaei Fathabadi F, et al. Effect of L-carnitine supplementation on maturation and early embryo development of immature mouse oocytes selected by brilliant cresyle blue staining. J Assist Reprod Genet 2015; 32: 635-643. [DOI:10.1007/s10815-015-0430-5]
24. Mishra A, Reddy IJ, Gupta PS, Mondal S. L-carnitine mediated reduction in oxidative stress and alteration in transcript level of antioxidant enzymes in sheep embryos produced in vitro. Reprod Domest Anim 2016; 51: 311-321. [DOI:10.1111/rda.12682]
25. Dunning KR, Russell DL, Robker RL. Lipids and oocyte developmental competence: the role of fatty acids and β-oxidation. Reproduction 2014; 148: R15-27. [DOI:10.1530/REP-13-0251]
26. Ribas GS, Vargas CR, Wajner M. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 2014; 533: 469-476. [DOI:10.1016/j.gene.2013.10.017]
27. Salviano MB, Collares FJ, Becker BS, Rodrigues BA, Rodrigues JL. Bovine non-competent oocytes (BCB-) negatively impact the capacity of competent (BCB+) oocytes to undergo in vitro maturation, fertilisation and embryonic development. Zygote 2016; 24: 245-251. [DOI:10.1017/S0967199415000118]
28. Mohapatra SK, Sandhu A, Neerukattu VS, Singh KP, Selokar NL, Singla SK, et al. Buffalo embryos produced by handmade cloning from oocytes selected using brilliant cresyl blue staining have better developmental competence and quality and are closer to embryos produced by in vitro fertilization in terms of their epigenetic status and gene expression pattern. Cell Reprogram 2015; 17: 141-150. [DOI:10.1089/cell.2014.0077]
29. Silva DS, Rodriguez P, Galuppo A, Arruda NS, Rodrigues JL. Selection of bovine oocytes by brilliant cresyl blue staining: effect on meiosis progression, organelle distribution and embryo development. Zygote 2013; 21: 250-255. [DOI:10.1017/S0967199411000487]
30. You J, Lee J, Hyun SH, Lee E. L-carnitine treatment during oocyte maturation improves in vitro development of cloned pig embryos by influencing intracellular glutathione synthesis and embryonic gene expression. Theriogenology 2012; 78: 235-243. [DOI:10.1016/j.theriogenology.2012.02.027]
31. Stojkovic M, Machado SA, Stojkovic P, Zakhartchenko V, Hutzler P, Goncalves PB, et al. Mitochondrial distribution and adenosine triphosphate content of bovine oocytes before and after in vitro maturation: correlation with morphological criteria and developmental capacity after in vitro fertilization and culture. Biol Reprod 2001; 64: 904-909. [DOI:10.1095/biolreprod64.3.904]
32. Khanmohammadi N, Movahedin M, Safari M, Sameni HR, Yousefi B, Jafari B, et al. Effect of L-carnitine on in vitro developmental rate, the zona pellucida and hatching of blastocysts and their cell numbers in mouse embryos. Int J Reprod Biomed (Yazd) 2016; 14: 649-656.
33. Knitlova D, Hulinska P, Jeseta M, Hanzalova K, Kempisty B, Machatkova M. Supplementation of l-carnitine during in vitro maturation improves embryo development from less competent bovine oocytes. Theriogenology 2017; 102: 16-22. [DOI:10.1016/j.theriogenology.2017.06.025]
34. Zhang DX, Park WJ, Sun SC, Xu YN, Li YH, Cui XS, et al. Regulation of maternal gene expression by MEK/MAPK and MPF signaling in porcine oocytes during in vitro meiotic maturation. J Reprod Dev 2011; 57: 49-56. [DOI:10.1262/jrd.10-087H]
35. Sirard MA, Richard F, Blondin P, Robert C. Contribution of the oocyte to embryo quality. Theriogenology 2006; 65: 126-136. [DOI:10.1016/j.theriogenology.2005.09.020]
36. Chankitisakul V, Somfai T, Inaba Y, Techakumphu M, Nagai T. Supplementation of maturation medium with L-carnitine improves cryo-tolerance of bovine in vitro matured oocytes. Theriogenology 2013; 79: 590-598. [DOI:10.1016/j.theriogenology.2012.11.011]
37. Sovernigo TC, Adona PR, Monzani PS, Guemra S, Barros F, Lopes FG, et al. Effects of supplementation of medium with different antioxidants during in vitro maturation of bovine oocytes on subsequent embryo production. Reprod Domest Anim 2017; 52: 561-569. [DOI:10.1111/rda.12946]
38. Tashiro F, Kanai-Azuma M, Miyazaki S, Kato M, Tanaka T, Toyoda S, et al. Maternal-effect gene Ces5/Ooep/Moep19/Floped is essential for oocyte cytoplasmic lattice formation and embryonic development at the maternal-zygotic stage transition. Genes Cells 2010; 15: 813-828. [DOI:10.1111/j.1365-2443.2010.01420.x]
39. Hu J, Wang F, Yuan Y, Zhu X, Wang Y, Zhang Y, et al. Novel importin-alpha family member Kpna7 is required for normal fertility and fecundity in the mouse. J Biol Chem 2010; 285: 33113-33122. [DOI:10.1074/jbc.M110.117044]
40. Dumollard R, Carroll J, Duchen MR, Campbell K, Swann K. Mitochondrial function and redox state in mammalian embryos. Semin Cell Dev Biol 2009; 20: 346-353. [DOI:10.1016/j.semcdb.2008.12.013]
41. Wu GQ, Jia BY, Li JJ, Fu XW, Zhou GB, Hou YP, et al. L-carnitine enhances oocyte maturation and development of parthenogenetic embryos in pigs. Theriogenology 2011; 76: 785-793. [DOI:10.1016/j.theriogenology.2011.04.011]
42. Ye J, Li J, Yu Y, Wei Q, Deng W, Yu L. L-carnitine attenuates oxidant injury in HK-2 cells via ROS-mitochondria pathway. Regul Pept 2010; 161: 58-66. [DOI:10.1016/j.regpep.2009.12.024]
43. Guo Y, Xiao P, Lei S, Deng F, Xiao GG, Liu Y, et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 426-436. [DOI:10.1111/j.1745-7270.2008.00418.x]
44. Zare Z, Tehrani M, Rafiei A, Valadan R, Mohammadi M. Differential expression of glutamate transporters in cerebral cortex of paraoxon-treated rats. Neurotoxicol Teratol 2017; 62: 20-26. [DOI:10.1016/j.ntt.2017.06.001]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb